AVITA Medical (RCEL) Non-Current Deffered Revenue (2019 - 2025)
AVITA Medical (RCEL) posted Non-Current Deffered Revenue of $290000.0 for Q4 2025, down 2.68% on a QoQ basis from $298000.0 in Q3 2025, and down 10.49% year-over-year from $324000.0 in Q4 2024.
AVITA Medical (RCEL) Non-Current Deffered Revenue (2019 - 2025) Analysis & Trends
AVITA Medical's Non-Current Deffered Revenue history runs 7 years deep, the most recent figure standing at $290000.0 for Q4 2025.
- Quarterly Non-Current Deffered Revenue fell 10.49% year-over-year to $290000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $290000.0 (down 10.49% YoY) and the FY2025 annual result came in at $290000.0, down 10.49% from the prior year.
- Non-Current Deffered Revenue was $290000.0 for Q4 2025 at AVITA Medical, down from $298000.0 in the prior quarter.
- Across five years, Non-Current Deffered Revenue topped out at $1.1 million in Q2 2021 and bottomed at $290000.0 in Q4 2025.
- A 5-year average of $561750.0 and a median of $369500.0 in 2023 frame the typical range for Non-Current Deffered Revenue.
- Annual changes were most pronounced in 2021 — Non-Current Deffered Revenue jumped 152.87% — and 2023, when it slumped 56.69%.
- AVITA Medical's Non-Current Deffered Revenue stood at $952000.0 in 2021, then retreated by 26.68% to $698000.0 in 2022, then slumped by 48.85% to $357000.0 in 2023, then declined by 9.24% to $324000.0 in 2024, then fell by 10.49% to $290000.0 in 2025.
- Business Quant data shows RCEL's Non-Current Deffered Revenue at $290000.0 in Q4 2025, $298000.0 in Q3 2025, and $307000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 512.79 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | AVITA Medical | 140.94 Mn | 124.59 Mn | 14.31 Mn | 290,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 290,000.00 |
| Sep 30, 2025 | 298,000.00 |
| Jun 30, 2025 | 307,000.00 |
| Mar 31, 2025 | 315,000.00 |
| Dec 31, 2024 | 324,000.00 |
| Sep 30, 2024 | 332,000.00 |
| Jun 30, 2024 | 340,000.00 |
| Mar 31, 2024 | 349,000.00 |
| Dec 31, 2023 | 357,000.00 |
| Sep 30, 2023 | 365,000.00 |
| Jun 30, 2023 | 374,000.00 |
| Mar 31, 2023 | 382,000.00 |
| Dec 31, 2022 | 698,000.00 |
| Sep 30, 2022 | 740,000.00 |
| Jun 30, 2022 | 813,000.00 |
| Mar 31, 2022 | 882,000.00 |
| Dec 31, 2021 | 952,000.00 |
| Sep 30, 2021 | 1.02 Mn |
| Jun 30, 2021 | 1.10 Mn |
| Mar 31, 2021 | 999,000.00 |